|Day Low/High||515.85 / 529.78|
|52 Wk Low/High||238.93 / 537.53|
As the Dow hits an all-time high while a pandemic rages on, who are those willing to look through the valley to the good numbers?
I'm not impressed by the markets' moves and they could easily foil even the best plans -- but here's how to position yourself.
I'd keep my eye on strength outside of earnings, and CRSR has been strong.
The 'work from home' or 'economic lockdown' trade is close to being back on.
Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.
What happens after this is likely a flurry of deals that will require more selling and that begins to cut into the tech stocks with much lower valuations like Facebook, Apple and Alphabet.
We're seeing the potential start of an epic deluge of new stock from companies that are private and eager to cash out, and guess who will be the losers?
First, let's closely watch this semiconductor company for the telecoms, and then examine the industrials, transports and retailers.
Along with many other big tech names, NOW has surged higher since our suggestion last week.
There is plenty of chasing of the strength which is an indication that FOMO is in overdrive again.
The company's backlog of revenue set to be recognized in the next 12 months grew much more strongly than expected.
The high dollar nature of the stock will scare some away, but the consolidation over the past two months is too much to ignore.
Don't confuse what's happening on the S&P with the nation's economy.
Both Apple and Tesla are chopping shares into pieces, which will let individual investors have a shot at buying them.
While valuations are clearly very high for many tech names, investor euphoria might not go away until news flow meaningfully worsens.
Anyone playing the guessing game into earnings is rolling the dice.
I would probably like to go into this Wednesday's earning report bearish, and here's my trade idea.
While we face some absolutely insane moves, we have to ask: Where are the sellers?
Let's review the charts, indicators and our strategy.
This list is not a buy list but a list of stocks that have been brought to new heights.
Infections are increasing across a number of highly populated U.S. states, and suddenly there's a rise in Beijing cases.
I don't have a cute acronym, but I guess we could say this is the GPS to find relative value.
I get this rally -- it's based on more than a breaking branch this time, but there are still many uncertainties.
SMAR is one of the few names not releasing earnings right now, and appears an attractive play.
I have told you before, this is not the firm to bet against. The problem is, or at least has been for me... timing a reentry point.